Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma
Clinical trial NCT05675462 · UNKNOWN
Trial details
- NCT number
- NCT05675462
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2025-12-30
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.